Armen Shanafelt, Director, 10% Owner at Surface Oncology, Inc. (SURF), bought 3,447,817 shares at $15.00 ($4.0M) on 2018-04-23, disclosed to the SEC on 2018-04-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,181,817 | $0 | 0.0% |
| 2 | $15.00 | 266,000 | $4.0M | 100.0% |
| Total | $1.16 avg | 3,447,817 | $4.0M | 100% |
| Filing → |
| PTGX | BUY | 2016-08-16 | $7.0M | — | Filing → |